Showing results (21-30 of 49) with videos related to
Sort By:
Pageof 5
Chemical Communications (Cambridge, England)|January 17, 2015
Identification of novel interactors of human telomeric G-quadruplex DNABruno Pagano, Luigi Margarucci, Pasquale Zizza, et al.European Journal of Medicinal Chemistry|December 12, 2018
Tailoring a lead-like compound targeting multiple G-quadruplex structuresJussara Amato, Chiara Platella, Sara Iachettini, et al.Biochimica Et Biophysica Acta. General Subjects|January 29, 2017
Tandem application of ligand-based virtual screening and G4-OAS assay to identify novel G-quadruplex-targeting chemotypesDomenica Musumeci, Jussara Amato, Pasquale Zizza, et al.Pharmaceutics|October 23, 2021
Identification of Effective Anticancer G-Quadruplex-Targeting Chemotypes through the Exploration of a High Diversity Library of Natural CompoundsChiara Platella, Francesca Ghirga, Pasquale Zizza, et al.Cancer Letters|March 3, 2022
TRF2 cooperates with CTCF for controlling the oncomiR-193b-3p in colorectal cancerRoberto Dinami, Eleonora Petti, Manuela Porru, et al.Nucleic Acids Research|January 26, 2015
A basal level of DNA damage and telomere deprotection increases the sensitivity of cancer cells to G-quadruplex interactive compoundsErica Salvati, Angela Rizzo, Sara Iachettini, et al.Journal of the American Chemical Society|November 14, 2014
Shading the TRF2 recruiting function: a new horizon in drug developmentSalvatore Di Maro, Pasquale Zizza, Erica Salvati, et al.Nucleic Acids Research|April 16, 2025
Naphthalene diimide-naphthalimide dyads promote telomere damage by selectively targeting multimeric G-quadruplexesValentina Pirota, Sara Iachettini, Chiara Platella, et al.Nucleic Acids Research|June 3, 2024
Unlocking the potential of protein-derived peptides to target G-quadruplex DNA: from recognition to anticancer activityFrancesco Merlino, Simona Marzano, Pasquale Zizza, et al.Journal of Medicinal Chemistry|April 27, 2017
Lead Discovery of Dual G-Quadruplex Stabilizers and Poly(ADP-ribose) Polymerases (PARPs) Inhibitors: A New Avenue in Anticancer TreatmentErica Salvati, Lorenzo Botta, Jussara Amato, et al.Pageof 5